Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E S Barnathan

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
JAMA|November 10, 1993
Has lipoprotein 'little' (a) shrunk?E S Barnathan
Current Opinion in Biotechnology|April 1, 1991
Thrombolytic therapy with tissue-type plasminogen activator: new modes and novel variant plasminogen activatorsG R Larsen, E S Barnathan
Journal of the American College of Cardiology|October 1, 1993
Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysisP T Vaitkus, E S Barnathan
Cardiovascular Clinics|January 1, 1988
Adjunctive pharmacologic treatmentE S Barnathan, J W Hirshfeld
Hospital Practice (Office Ed.)|December 15, 1994
Angioplasty in multivessel coronary artery diseaseW B Bachinsky, E S Barnathan
Nucleic Acids Research|May 11, 1994
Rapid method for screening and cloning cDNAs generated in differential mRNA display: application of northern blot for affinity capturing of cDNAsF Li, E S Barnathan, K Karikó
Circulation|December 13, 1997
Images in cardiovascular medicine. Left anterior descending coronary artery-to-right ventricle fistulaD DeNofrio, E S Barnathan, E Loh
The American Journal of Physiology|January 1, 1982
Interaction of verapamil with human platelet alpha-adrenergic receptorsE S Barnathan, V P Addonizio, S J Shattil
Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 1996
Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasionS S Okada, S R Grobmyer, E S Barnathan
FEBS Letters|September 19, 1994
Lipofectin-aided cell delivery of ribozyme targeted to human urokinase receptor mRNAK Karikó, K Megyeri, Q Xiao, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
JAMA|November 10, 1993
Has lipoprotein 'little' (a) shrunk?E S Barnathan
Current Opinion in Biotechnology|April 1, 1991
Thrombolytic therapy with tissue-type plasminogen activator: new modes and novel variant plasminogen activatorsG R Larsen, E S Barnathan
Journal of the American College of Cardiology|October 1, 1993
Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysisP T Vaitkus, E S Barnathan
Cardiovascular Clinics|January 1, 1988
Adjunctive pharmacologic treatmentE S Barnathan, J W Hirshfeld
Hospital Practice (Office Ed.)|December 15, 1994
Angioplasty in multivessel coronary artery diseaseW B Bachinsky, E S Barnathan
Nucleic Acids Research|May 11, 1994
Rapid method for screening and cloning cDNAs generated in differential mRNA display: application of northern blot for affinity capturing of cDNAsF Li, E S Barnathan, K Karikó
Circulation|December 13, 1997
Images in cardiovascular medicine. Left anterior descending coronary artery-to-right ventricle fistulaD DeNofrio, E S Barnathan, E Loh
The American Journal of Physiology|January 1, 1982
Interaction of verapamil with human platelet alpha-adrenergic receptorsE S Barnathan, V P Addonizio, S J Shattil
Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 1996
Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasionS S Okada, S R Grobmyer, E S Barnathan
FEBS Letters|September 19, 1994
Lipofectin-aided cell delivery of ribozyme targeted to human urokinase receptor mRNAK Karikó, K Megyeri, Q Xiao, et al.
Pageof 6